The drugmaker hopes to show CagriSema leads to at least 25% weight loss, without increased side effects. Its lead in a ...

Lives lost to obesity-related heart disease have nearly tripled over the past 20 years, a new study reports. Heart disease deaths linked to obesity increased 2.8-fold between 1999 and 2020, according ...

the annual meeting of The Obesity Society. The first abstract comprises outcomes data from Allurion’s largest real-world cohort on record. The data, gathered from 19,428 patients across 72 ...

Obesity has reached epidemic proportions across the globe ... Pennington Biomedical has the vision to lead the world in promoting metabolic health and eliminating metabolic disease through ...

Learn about research at MSK that finds obesity can influence driver mutations that produce specific subtypes of cancers, ...

Despite any potential detriments, demand in the civilian world for weight ... obese populations across the country. In 2022, all U.S. states and territories reported an obesity prevalence of ...

A nationwide study from Japan spanning a 14-year study period has revealed an increasing trend of overweight and obesity in ...

A global “stroke epidemic” is looming - growing rates of diabetes and obesity across the world coupled with lack of exercise have led to the number of strokes afflicting people aged between 20 ...

The Independent is trusted by 27 million Americans from across the entire political ... and Lilly will examine the “real-world effectiveness” of anti-obesity treatment Mounjaro, also known ...

Allurion Technologies, Inc. (NYSE: ALUR), a company dedicated to ending obesity, today announced the presentation of two abstracts at Obesity Week 2024, the annual meeting of The Obesity Society.